Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Pharmacokinetic Assay
1.2.3 Tiered Immunogenicity Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosimilar Testing Service Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing Service Market Perspective (2018-2033)
2.2 Biosimilar Testing Service Growth Trends by Region
2.2.1 Global Biosimilar Testing Service Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biosimilar Testing Service Historic Market Size by Region (2018-2023)
2.2.3 Biosimilar Testing Service Forecasted Market Size by Region (2024-2033)
2.3 Biosimilar Testing Service Market Dynamics
2.3.1 Biosimilar Testing Service Industry Trends
2.3.2 Biosimilar Testing Service Market Drivers
2.3.3 Biosimilar Testing Service Market Challenges
2.3.4 Biosimilar Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Testing Service Players by Revenue
3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2018-2023)
3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Testing Service Revenue
3.4 Global Biosimilar Testing Service Market Concentration Ratio
3.4.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2022
3.5 Biosimilar Testing Service Key Players Head office and Area Served
3.6 Key Players Biosimilar Testing Service Product Solution and Service
3.7 Date of Enter into Biosimilar Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing Service Breakdown Data by Type
4.1 Global Biosimilar Testing Service Historic Market Size by Type (2018-2023)
4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2024-2033)
5 Biosimilar Testing Service Breakdown Data by Application
5.1 Global Biosimilar Testing Service Historic Market Size by Application (2018-2023)
5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biosimilar Testing Service Market Size (2018-2033)
6.2 North America Biosimilar Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Biosimilar Testing Service Market Size by Country (2018-2023)
6.4 North America Biosimilar Testing Service Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Testing Service Market Size (2018-2033)
7.2 Europe Biosimilar Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Biosimilar Testing Service Market Size by Country (2018-2023)
7.4 Europe Biosimilar Testing Service Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Testing Service Market Size (2018-2033)
8.2 Asia-Pacific Biosimilar Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Biosimilar Testing Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Biosimilar Testing Service Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Testing Service Market Size (2018-2033)
9.2 Latin America Biosimilar Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Biosimilar Testing Service Market Size by Country (2018-2023)
9.4 Latin America Biosimilar Testing Service Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Testing Service Market Size (2018-2033)
10.2 Middle East & Africa Biosimilar Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Biosimilar Testing Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Biosimilar Testing Service Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories International
11.1.1 Charles River Laboratories International Company Detail
11.1.2 Charles River Laboratories International Business Overview
11.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction
11.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2018-2023)
11.1.5 Charles River Laboratories International Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Biosimilar Testing Service Introduction
11.2.4 Merck Revenue in Biosimilar Testing Service Business (2018-2023)
11.2.5 Merck Recent Development
11.3 PPD
11.3.1 PPD Company Detail
11.3.2 PPD Business Overview
11.3.3 PPD Biosimilar Testing Service Introduction
11.3.4 PPD Revenue in Biosimilar Testing Service Business (2018-2023)
11.3.5 PPD Recent Development
11.4 LAB Holdings
11.4.1 LAB Holdings Company Detail
11.4.2 LAB Holdings Business Overview
11.4.3 LAB Holdings Biosimilar Testing Service Introduction
11.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2018-2023)
11.4.5 LAB Holdings Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Biosimilar Testing Service Introduction
11.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2018-2023)
11.5.5 Eurofins Scientific Recent Development
11.6 Intertek
11.6.1 Intertek Company Detail
11.6.2 Intertek Business Overview
11.6.3 Intertek Biosimilar Testing Service Introduction
11.6.4 Intertek Revenue in Biosimilar Testing Service Business (2018-2023)
11.6.5 Intertek Recent Development
11.7 SGS
11.7.1 SGS Company Detail
11.7.2 SGS Business Overview
11.7.3 SGS Biosimilar Testing Service Introduction
11.7.4 SGS Revenue in Biosimilar Testing Service Business (2018-2023)
11.7.5 SGS Recent Development
11.8 Profacgen
11.8.1 Profacgen Company Detail
11.8.2 Profacgen Business Overview
11.8.3 Profacgen Biosimilar Testing Service Introduction
11.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2018-2023)
11.8.5 Profacgen Recent Development
11.9 Antibody Analytics
11.9.1 Antibody Analytics Company Detail
11.9.2 Antibody Analytics Business Overview
11.9.3 Antibody Analytics Biosimilar Testing Service Introduction
11.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2018-2023)
11.9.5 Antibody Analytics Recent Development
11.10 Kymos Pharma Services
11.10.1 Kymos Pharma Services Company Detail
11.10.2 Kymos Pharma Services Business Overview
11.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction
11.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2018-2023)
11.10.5 Kymos Pharma Services Recent Development
11.11 Medicilon
11.11.1 Medicilon Company Detail
11.11.2 Medicilon Business Overview
11.11.3 Medicilon Biosimilar Testing Service Introduction
11.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2018-2023)
11.11.5 Medicilon Recent Development
11.12 Pacific BioLabs
11.12.1 Pacific BioLabs Company Detail
11.12.2 Pacific BioLabs Business Overview
11.12.3 Pacific BioLabs Biosimilar Testing Service Introduction
11.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2018-2023)
11.12.5 Pacific BioLabs Recent Development
11.13 Sartorius
11.13.1 Sartorius Company Detail
11.13.2 Sartorius Business Overview
11.13.3 Sartorius Biosimilar Testing Service Introduction
11.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2018-2023)
11.13.5 Sartorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biosimilar Testing Service Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Pharmacokinetic Assay
Table 3. Key Players of Tiered Immunogenicity Testing
Table 4. Key Players of Others
Table 5. Global Biosimilar Testing Service Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Biosimilar Testing Service Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Biosimilar Testing Service Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Biosimilar Testing Service Market Share by Region (2018-2023)
Table 9. Global Biosimilar Testing Service Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Biosimilar Testing Service Market Share by Region (2024-2033)
Table 11. Biosimilar Testing Service Market Trends
Table 12. Biosimilar Testing Service Market Drivers
Table 13. Biosimilar Testing Service Market Challenges
Table 14. Biosimilar Testing Service Market Restraints
Table 15. Global Biosimilar Testing Service Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Biosimilar Testing Service Market Share by Players (2018-2023)
Table 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2022)
Table 18. Ranking of Global Top Biosimilar Testing Service Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Biosimilar Testing Service Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biosimilar Testing Service Product Solution and Service
Table 22. Date of Enter into Biosimilar Testing Service Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosimilar Testing Service Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Biosimilar Testing Service Revenue Market Share by Type (2018-2023)
Table 26. Global Biosimilar Testing Service Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Biosimilar Testing Service Revenue Market Share by Type (2024-2033)
Table 28. Global Biosimilar Testing Service Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Biosimilar Testing Service Revenue Market Share by Application (2018-2023)
Table 30. Global Biosimilar Testing Service Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Biosimilar Testing Service Revenue Market Share by Application (2024-2033)
Table 32. North America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Biosimilar Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Biosimilar Testing Service Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Biosimilar Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Biosimilar Testing Service Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Biosimilar Testing Service Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Biosimilar Testing Service Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Biosimilar Testing Service Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Biosimilar Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Biosimilar Testing Service Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Biosimilar Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Biosimilar Testing Service Market Size by Country (2024-2033) & (US$ Million)
Table 47. Charles River Laboratories International Company Detail
Table 48. Charles River Laboratories International Business Overview
Table 49. Charles River Laboratories International Biosimilar Testing Service Product
Table 50. Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 51. Charles River Laboratories International Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Biosimilar Testing Service Product
Table 55. Merck Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 56. Merck Recent Development
Table 57. PPD Company Detail
Table 58. PPD Business Overview
Table 59. PPD Biosimilar Testing Service Product
Table 60. PPD Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 61. PPD Recent Development
Table 62. LAB Holdings Company Detail
Table 63. LAB Holdings Business Overview
Table 64. LAB Holdings Biosimilar Testing Service Product
Table 65. LAB Holdings Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 66. LAB Holdings Recent Development
Table 67. Eurofins Scientific Company Detail
Table 68. Eurofins Scientific Business Overview
Table 69. Eurofins Scientific Biosimilar Testing Service Product
Table 70. Eurofins Scientific Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 71. Eurofins Scientific Recent Development
Table 72. Intertek Company Detail
Table 73. Intertek Business Overview
Table 74. Intertek Biosimilar Testing Service Product
Table 75. Intertek Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 76. Intertek Recent Development
Table 77. SGS Company Detail
Table 78. SGS Business Overview
Table 79. SGS Biosimilar Testing Service Product
Table 80. SGS Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 81. SGS Recent Development
Table 82. Profacgen Company Detail
Table 83. Profacgen Business Overview
Table 84. Profacgen Biosimilar Testing Service Product
Table 85. Profacgen Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 86. Profacgen Recent Development
Table 87. Antibody Analytics Company Detail
Table 88. Antibody Analytics Business Overview
Table 89. Antibody Analytics Biosimilar Testing Service Product
Table 90. Antibody Analytics Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 91. Antibody Analytics Recent Development
Table 92. Kymos Pharma Services Company Detail
Table 93. Kymos Pharma Services Business Overview
Table 94. Kymos Pharma Services Biosimilar Testing Service Product
Table 95. Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 96. Kymos Pharma Services Recent Development
Table 97. Medicilon Company Detail
Table 98. Medicilon Business Overview
Table 99. Medicilon Biosimilar Testing Service Product
Table 100. Medicilon Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 101. Medicilon Recent Development
Table 102. Pacific BioLabs Company Detail
Table 103. Pacific BioLabs Business Overview
Table 104. Pacific BioLabs Biosimilar Testing Service Product
Table 105. Pacific BioLabs Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 106. Pacific BioLabs Recent Development
Table 107. Sartorius Company Detail
Table 108. Sartorius Business Overview
Table 109. Sartorius Biosimilar Testing Service Product
Table 110. Sartorius Revenue in Biosimilar Testing Service Business (2018-2023) & (US$ Million)
Table 111. Sartorius Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Testing Service Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Biosimilar Testing Service Market Share by Type: 2022 VS 2033
Figure 3. Pharmacokinetic Assay Features
Figure 4. Tiered Immunogenicity Testing Features
Figure 5. Others Features
Figure 6. Global Biosimilar Testing Service Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Biosimilar Testing Service Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Biosimilar Testing Service Report Years Considered
Figure 12. Global Biosimilar Testing Service Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Biosimilar Testing Service Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Biosimilar Testing Service Market Share by Region: 2022 VS 2033
Figure 15. Global Biosimilar Testing Service Market Share by Players in 2022
Figure 16. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biosimilar Testing Service Revenue in 2022
Figure 18. North America Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Biosimilar Testing Service Market Share by Country (2018-2033)
Figure 20. United States Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Biosimilar Testing Service Market Share by Country (2018-2033)
Figure 24. Germany Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Biosimilar Testing Service Market Share by Region (2018-2033)
Figure 32. China Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Biosimilar Testing Service Market Share by Country (2018-2033)
Figure 40. Mexico Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Biosimilar Testing Service Market Share by Country (2018-2033)
Figure 44. Turkey Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Biosimilar Testing Service Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Charles River Laboratories International Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 48. PPD Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 49. LAB Holdings Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 50. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 51. Intertek Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 52. SGS Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 53. Profacgen Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 54. Antibody Analytics Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 55. Kymos Pharma Services Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 56. Medicilon Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 57. Pacific BioLabs Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 58. Sartorius Revenue Growth Rate in Biosimilar Testing Service Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed